These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 9136987)

  • 21. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
    Pagano E; Calvo JC
    J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two modes of ERK activation by TNF in keratinocytes: different cellular outcomes and bi-directional modulation by vitamin D.
    Ziv E; Rotem C; Miodovnik M; Ravid A; Koren R
    J Cell Biochem; 2008 May; 104(2):606-19. PubMed ID: 18080320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
    Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
    Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
    Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
    Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
    J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
    Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
    Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos.
    Scapoli L; Ramos-Nino ME; Martinelli M; Mossman BT
    Oncogene; 2004 Jan; 23(3):805-13. PubMed ID: 14737115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling.
    Drube S; Stirnweiss J; Valkova C; Liebmann C
    Cell Signal; 2006 Oct; 18(10):1633-46. PubMed ID: 16495036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
    Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
    Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta.
    Denning MF; Dlugosz AA; Threadgill DW; Magnuson T; Yuspa SH
    J Biol Chem; 1996 Mar; 271(10):5325-31. PubMed ID: 8621384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC; Miyake T; Parsons SJ
    Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
    Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
    Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes.
    Zyzak LL; MacDonald LM; Batova A; Forand R; Creek KE; Pirisi L
    Cell Growth Differ; 1994 May; 5(5):537-47. PubMed ID: 8049160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells.
    Sako T; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
    Cancer Res; 1987 Oct; 47(20):5445-50. PubMed ID: 2888531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of EGF, TGF-alpha, EGFR and c-erbB2 genes and their gene products in human pancreatic carcinoma cell lines.
    Chen J; Liu TH
    Zentralbl Pathol; 1994 Aug; 140(3):265-70. PubMed ID: 7947634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
    Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation.
    Hoesl C; Röhrl JM; Schneider MR; Dahlhoff M
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):958-966. PubMed ID: 29410073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.